Canagliflozin vs Pembrolizumab

## Canagliflozin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Pembrolizumab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Pembrolizumab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Pembrolizumab — N/A.

**Type**: Canagliflozin — Small molecule; Pembrolizumab — Antibody.